Total and High-Molecular-Weight Adiponectin and Risk of Incident Diabetes in Older People
暂无分享,去创建一个
C. Mantzoros | D. Siscovick | S. Zieman | A. Arnold | L. Djoussé | J. Ix | R. Tracy | J. Kizer | K. Mukamal | D. Benkeser | J. Barzilay | Russell P. Tracy | Alice M. Arnold | Christos S. Mantzoros
[1] C. Mantzoros,et al. Effects of leptin and adiponectin on pancreatic β-cell function. , 2011, Metabolism: clinical and experimental.
[2] S. Kritchevsky,et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.
[3] W. Rathmann,et al. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study , 2011, Diabetologia.
[4] J. Pankow,et al. High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. , 2010, The Journal of clinical endocrinology and metabolism.
[5] D. Mozaffarian,et al. Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older Adults , 2010 .
[6] D. Mozaffarian,et al. Association between adiposity in midlife and older age and risk of diabetes in older adults. , 2010, JAMA.
[7] L. Fried,et al. Long‐Term Function in an Older Cohort—The Cardiovascular Health Study All Stars Study , 2009, Journal of the American Geriatrics Society.
[8] Desmond E. Williams,et al. Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006 , 2009, Diabetes Care.
[9] F. Hu,et al. Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in Women , 2008, Annals of Internal Medicine.
[10] N. Sattar,et al. Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. , 2008, The Journal of clinical endocrinology and metabolism.
[11] Frank A Sloan,et al. The growing burden of diabetes mellitus in the US elderly population. , 2008, Archives of internal medicine.
[12] M. Lazar,et al. Mechanisms of obesity-associated insulin resistance: many choices on the menu. , 2007, Genes & development.
[13] T. Funahashi,et al. Associations of Adiponectin Levels With Incident Impaired Glucose Metabolism and Type 2 Diabetes in Older Men and Women , 2006, Diabetes Care.
[14] A. Nakashima,et al. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. , 2006, The Journal of clinical endocrinology and metabolism.
[15] Kohjiro Ueki,et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.
[16] S. Cummings,et al. Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. , 2006, Archives of internal medicine.
[17] John A Wagner,et al. Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.
[18] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[19] L. Kuller,et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.
[20] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[21] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[22] H. Chui,et al. The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.
[23] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[24] J. Stockman. Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis , 2011 .
[25] D. Mozaffarian,et al. Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. , 2011, American journal of epidemiology.
[26] C. Mantzoros,et al. Adiponectin in insulin resistance: lessons from translational research. , 2010, The American journal of clinical nutrition.
[27] Stefan Sperlich,et al. Generalized Additive Models , 2014 .
[28] R. Tracy,et al. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.
[29] 浜田賀代子,et al. 老年期痴呆患者のスクリーニングにおけるThe modified mini-mental state (3MS) examination日本語版の有用性 , 1992 .